RAD51AP1 and ovarian carcinoma: RAD51AP1 was considered a novel biomarker for ovarian cancer diagnosis, and high expression of RAD51AP1 is associated with poorer overall survival (OS) in patients with ovarian cancer (Chudasama et al. 2018).